Insider Selling: OrthoPediatrics (NASDAQ:KIDS) Major Shareholder Sells $403,262.00 in Stock

OrthoPediatrics Corp. (NASDAQ:KIDS) major shareholder Jennifer Pritzker sold 16,300 shares of OrthoPediatrics stock in a transaction on Tuesday, August 25th. The shares were sold at an average price of $24.74, for a total transaction of $403,262.00. Following the completion of the sale, the insider directly owned 6,881,464 shares of the company’s stock, valued at approximately $170,247,419.36. The trade was a 0.24% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Large shareholders that own 10% or more of a company’s shares are required to disclose their sales and purchases with the SEC.

OrthoPediatrics Stock Up 1.4%

KIDS opened at $23.65 on Friday. The business has a 50 day moving average price of $21.41 and a 200 day moving average price of $18.66. OrthoPediatrics Corp. has a twelve month low of $14.42 and a twelve month high of $26.74. The company has a debt-to-equity ratio of 0.28, a quick ratio of 2.17 and a current ratio of 4.78. The firm has a market cap of $617.50 million, a P/E ratio of -14.08 and a beta of 0.98.

OrthoPediatrics (NASDAQ:KIDS) last posted its quarterly earnings data on Tuesday, August 4th. The company reported ($0.26) EPS for the quarter, topping analysts’ consensus estimates of ($0.30) by $0.04. The business had revenue of $70.51 million for the quarter, compared to analyst estimates of $68.21 million. OrthoPediatrics had a negative return on equity of 8.10% and a negative net margin of 15.72%. Research analysts forecast that OrthoPediatrics Corp. will post -1.14 EPS for the current year.

Analysts Set New Price Targets

KIDS has been the topic of several research reports. Weiss Ratings upgraded shares of OrthoPediatrics from a “sell (e+)” rating to a “sell (d-)” rating in a report on Wednesday, August 5th. Truist Financial set a $22.00 target price on OrthoPediatrics in a research report on Wednesday, August 5th. Piper Sandler restated an “overweight” rating and set a $25.00 price target (up from $22.00) on shares of OrthoPediatrics in a research note on Wednesday, August 5th. TD Cowen restated a “buy” rating on shares of OrthoPediatrics in a research note on Monday, June 15th. Finally, Needham & Company LLC lifted their target price on shares of OrthoPediatrics from $30.00 to $35.00 and gave the company a “buy” rating in a research report on Wednesday, August 5th. Nine research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, OrthoPediatrics presently has a consensus rating of “Moderate Buy” and a consensus target price of $26.44.

Institutional Trading of OrthoPediatrics

Several hedge funds have recently modified their holdings of KIDS. AIGH Capital Management LLC acquired a new position in shares of OrthoPediatrics in the 2nd quarter worth approximately $5,161,000. Wasatch Advisors LP increased its holdings in OrthoPediatrics by 56.6% during the 2nd quarter. Wasatch Advisors LP now owns 515,677 shares of the company’s stock valued at $9,865,000 after purchasing an additional 186,357 shares in the last quarter. Roubaix Capital LLC raised its position in OrthoPediatrics by 23.8% in the 1st quarter. Roubaix Capital LLC now owns 290,047 shares of the company’s stock valued at $4,603,000 after purchasing an additional 55,724 shares during the last quarter. Granahan Investment Management LLC raised its position in OrthoPediatrics by 35.1% in the 1st quarter. Granahan Investment Management LLC now owns 896,741 shares of the company’s stock valued at $14,231,000 after purchasing an additional 232,760 shares during the last quarter. Finally, AWM Investment Company Inc. acquired a new position in OrthoPediatrics in the second quarter worth $4,537,000. Institutional investors and hedge funds own 69.05% of the company’s stock.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., founded in 2007 and headquartered in Warsaw, Indiana, is a medical device company dedicated exclusively to providing orthopedic solutions for children. The company focuses on developing, manufacturing and marketing a broad portfolio of implants and instruments designed to address a wide range of pediatric conditions, including trauma, deformity correction, spine disorders and sports injuries.

The company’s product lines include locking plates and screws for upper and lower extremity reconstruction, intramedullary nails for femur and tibia stabilization, and specialized systems such as the MAGEC Magnetic Growth Rod for treatment of early-onset scoliosis.